Current clinical applications of botulinum toxin

Current Pharmaceutical Design
Daniel D TruongGerhard Reichel

Abstract

Botulinum toxin has long been known for its paralytic effects on the human voluntary musculature via inhibition of acetylcholine release at neuromuscular junctions. Its original clinical use for the treatment of strabismus has expanded significantly to include neurological conditions related to muscle hyperactivity and/or spasticity (e.g., dystonia, spasticity, tics, tremor, dysphonia). Recently, botulinum toxin has been shown to impact autonomic disorders by acting at acceptors on glands and smooth muscle, and consequently it has been used in the management of a number of other conditions including hypersecretory disorders, pain syndromes, detrusor sphinchter dyssenergia or overactivity and gastointestinal smooth muscle/sphincter spasm; it may also reduce pain in patients for whom it is used to treat these and other primary conditions. This article will review the pharmacology and formulations of botulinum toxins as well as data from clinical trials demonstrating their efficacy for numerous conditions based on their effects on cholinergic synapses outside the motor nervous system.

Citations

Apr 7, 2012·American Journal of Therapeutics·Norman S Levy, David T Lowenthal
Nov 10, 2011·Toxins·Assaf Shapira, Itai Benhar
Jun 11, 2014·Progress in Neurobiology·Ivica Matak, Zdravko Lacković
Nov 30, 2014·Neurologic Clinics·H A Jinnah, Stewart A Factor
Dec 4, 2010·FEBS Letters·Christina L PierEric A Johnson
Feb 17, 2015·Journal of the Neurological Sciences·Andrea SantamatoFrancesco Panza
Oct 20, 2010·The Urologic Clinics of North America·Marc C SmaldoneWendy W Leng
Nov 1, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D Dressler
Jul 31, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Dirk DresslerHans Bigalke
Jul 16, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D Dressler
Mar 24, 2016·Journal of Neural Transmission·Dirk DresslerHans Bigalke
Apr 25, 2013·Parkinsonism & Related Disorders·Roberto ErroCarla Cordivari
Mar 17, 2011·The Biochemical Journal·Charles S CraikEdwin L Madison
Jul 18, 2014·Journal of Neural Transmission·Dirk DresslerChristoph Schrader
Nov 12, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Ammar Nassri, Zeeshan Ramzan
Nov 26, 2015·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Chetan P PhadkeChris Boulias
Jan 1, 2015·Global Pediatric Health·Eman M I Moawad, Enas Abdallah Ali Abdallah
Feb 28, 2021·Fortschritte der Neurologie-Psychiatrie·Kazuya Yoshida
Oct 17, 2013·Journal of Medicinal Chemistry·Peter SilhárKim D Janda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Related Papers

Current Opinion in Pharmacology
C Montecucco, Jordi Molgó
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
A B WardA Berardelli
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
D Dressler
Toxicon : Official Journal of the International Society on Toxinology
Joseph Jankovic
© 2022 Meta ULC. All rights reserved